InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
4
T+90 hit rate
33%
T+90 mean return
-7.0%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Fox Allan M., Director. Officer active across 1 company, notably REGENXBIO Inc.. Aggregated, 7 disclosures have been published. Split: 0 buy · 4 sells. Total volume traded: €7.4m. Activity tracked since 17 September 2021. The latest transaction was disclosed on 31 May 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
4,790 shares0Common StockSEC:0001562180-24-004651:0
3,486 shares0Common StockSEC:0001562180-23-004896:0
3,010 shares0Common StockSEC:0001562180-22-004875:0
61,638 shares@ US$34.40370.64% mcap25.2% of flowCommon StockSEC:0001562180-21-007876:0
61,638 shares@ US$34.403725.2% of flowCommon StockSEC:0001562180-21-007876
48,233 shares@ US$45.03810.62% mcap24.8% of flowCommon StockSEC:0000899243-21-036773:0
48,233 shares@ US$45.038124.8% of flowCommon StockSEC:0000899243-21-036773
7 of 7 declarations
About Fox Allan M.
Allan M. Fox serves as a Director at REGENXBIO Inc. In this role, he participates in the governance of the company and strategic decision-making. Allan brings significant experience in the biopharmaceutical sector, enabling him to contribute to discussions on the direction and performance of the company. His expertise helps REGENXBIO achieve its growth objectives.
